Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,610 | 53,610 | 3,200 | 4,520 | 8,200 |
| Other current assets | 540 | 400 | 490 | 540 | 770 |
| TOTAL | $50,150 | $54,010 | $3,690 | $5,060 | $8,970 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 870 | 820 | N/A |
| Other Non-Current Assets | 14,600 | 4,680 | 5,170 | 4,760 | 4,820 |
| TOTAL | $14,600 | $4,680 | $6,040 | $5,580 | $4,820 |
| Total Assets | $65,120 | $58,970 | $9,180 | $10,110 | $14,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 850 | 720 | 1,320 | 990 | 290 |
| Accrued Expenses | 2,120 | 1,460 | 2,430 | 2,070 | 2,470 |
| Other current liabilities | 10,000 | 0 | 0 | 0 | 0 |
| TOTAL | $12,970 | $2,180 | $6,480 | $6,940 | $4,050 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 1,730 | 0 | 2,750 |
| TOTAL | $N/A | $N/A | $1,730 | $N/A | $2,750 |
| Total Liabilities | $12,970 | $2,180 | $8,210 | $6,940 | $6,800 |
| Shareholders' Equity | |||||
| Common Shares | 450 | 2,730 | 680 | 680 | 680 |
| Retained earnings | -273,340 | -268,330 | -261,720 | -255,800 | -251,680 |
| Other shareholders' equity | 10 | 0 | 10 | 10 | 0 |
| TOTAL | $52,150 | $56,780 | $960 | $3,170 | $7,280 |
| Total Liabilities And Equity | $65,120 | $58,960 | $9,170 | $10,110 | $14,080 |